Nizar A. Al‐Shar’i

Evaluation and Characterization of Curcumin-β-Cyclodextrin and Cyclodextrin-Based Nanosponge Inclusion Complexation

Hadeia Mashaqbeh, Rana Obaidat, Nizar A. Al‐Shar’i · Polymers · 2021 · 102 citations · Full text

<i>In vitro</i> anti-TB properties, <i>in silico</i> target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against <i>Mycobacterium tuberculosis</i>

Pran Kishore Deb, Nizar A. Al‐Shar’i, Katharigatta N. Venugopala et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2021 · 55 citations · Full text

Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme

Katharigatta N. Venugopala, Sandeep Chandrashekharappa, Pran Kishore Deb et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2021 · 49 citations · Full text

Enhanced Antimicrobial Activity of AamAP1-Lysine, a Novel Synthetic Peptide Analog Derived from the Scorpion Venom Peptide AamAP1

Ammar Almaaytah, Shadi Tarazi, Ahmad Abualhaijaa et al. · Pharmaceuticals · 2014 · 46 citations · Full text

Medicinal Chemistry, Antimicrobial Drug Discovery, Parent Peptide +15

Novel glyoxalase-I inhibitors possessing a &amp;ldquo;zinc-binding feature&amp;rdquo; as potential anticancer agents

Qosay Al‐Balas, Mohammad A. Hassan, Nizar A. Al‐Shar’i et al. · Drug Design Development and Therapy · 2016 · 29 citations · Full text